Tuesday, 15 September 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.

from NDTV News - Special https://ift.tt/2Rxkbqa
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

ICICI Bank Made Offer To Acquire HDFC Ltd Before Reverse Merger: Ex-Chairman Deepak Parekh

Veteran banker and former chairman of HDFC Ltd, Deepak Parekh, has said that ICICI Bank had made an offer to take over mortgage lender HDFC ...